Integrative cancer epidemiology--the next generation

scientific article

Integrative cancer epidemiology--the next generation is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1158/2159-8290.CD-12-0424
P932PMC publication ID3531829
P698PubMed publication ID23230187

P50authorNeil CaporasoQ107095573
P2093author name stringMargaret R Spitz
Thomas A Sellers
P2860cites workOpportunities and barriers in the age of team science: strategies for successQ36401483
Predisposition gene identification in common cancers by exome sequencing: insights from familial breast cancerQ37194147
Invited commentary: from genome-wide association studies to gene-environment-wide interaction studies--challenges and opportunitiesQ37306204
Uncovering the roles of rare variants in common disease through whole-genome sequencingQ37755970
Bigger, better, sooner--scaling up for successQ39646776
Molecular cancer epidemiology: a new tool in cancer preventionQ41327207
Population-based and family-based designs to analyze rare variants in complex diseasesQ41886407
Landmarks in the history of cancer epidemiologyQ43464532
Epidemiology faces its limits.Q52877590
Integrative study designs--next step in the evolution of molecular epidemiology?Q79986196
The beginning of the end for the epidemiologic focus on gene-environment interactions?Q83994654
An Environment-Wide Association Study (EWAS) on type 2 diabetes mellitusQ21136362
Interdisciplinary education to integrate pathology and epidemiology: towards molecular and population-level health scienceQ24289208
Lifestyle factors and microsatellite instability in colorectal cancer: the evolving field of molecular pathological epidemiologyQ24622814
Radiomics: the process and the challengesQ26865378
Epigenome-wide association studies for common human diseasesQ28710498
Systematic identification of genomic markers of drug sensitivity in cancer cellsQ29547695
T (brachyury) gene duplication confers major susceptibility to familial chordomaQ33273533
Can genes for mammographic density inform cancer aetiology?Q33635885
Strengthening the reporting of Genetic RIsk Prediction Studies: the GRIPS StatementQ33851304
Gene--environment-wide association studies: emerging approachesQ33937986
Next generation analytic tools for large scale genetic epidemiology studies of complex diseasesQ34029677
STrengthening the Reporting of OBservational studies in Epidemiology--Molecular Epidemiology (STROBE-ME): an extension of the STROBE StatementQ34062156
The Emergence of Translational Epidemiology: From Scientific Discovery to Population Health ImpactQ34082166
A novel two-stage, transdisciplinary study identifies digoxin as a possible drug for prostate cancer treatmentQ35581883
Integrative epidemiology: from risk assessment to outcome predictionQ36002142
Frontiers in cancer epidemiology: a challenge to the research community from the Epidemiology and Genomics Research Program at the National Cancer InstituteQ36083974
P433issue12
P407language of work or nameEnglishQ1860
P921main subjectepidemiologyQ133805
P304page(s)1087-90
P577publication date2012-12-01
P1433published inCancer DiscoveryQ15724440
P1476titleIntegrative cancer epidemiology--the next generation
P478volume2

Reverse relations

cites work (P2860)
Q38743221Association of breast cancer risk and the mTOR pathway in women of African ancestry in 'The Root' Consortium
Q40580231Association of the genetic diversity of killer cell immunoglobulin-like receptor genes and HLA-C ligand in Saudi women with breast cancer
Q36819754Bridging the gap between biologic, individual, and macroenvironmental factors in cancer: a multilevel approach
Q24658639Charting a future for epidemiologic training
Q27011884Discovery of colorectal cancer PIK3CA mutation as potential predictive biomarker: power and promise of molecular pathological epidemiology
Q35098158Epidemiological study of prostate cancer (EPICAP): a population-based case-control study in France
Q26852716Etiologic field effect: reappraisal of the field effect concept in cancer predisposition and progression
Q36463854Integration of molecular pathology, epidemiology and social science for global precision medicine
Q37075412Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication
Q24289344Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease
Q37172368Phospholipase A2G1B polymorphisms and risk of colorectal neoplasia.
Q36926941Physical activity, tumor PTGS2 expression, and survival in patients with colorectal cancer
Q37360360Predictive and prognostic analysis of PIK3CA mutation in stage III colon cancer intergroup trial.
Q34475686Proceedings of the second international molecular pathological epidemiology (MPE) meeting
Q34016833Progress and opportunities in molecular pathological epidemiology of colorectal premalignant lesions
Q36410322Provocative questions in cancer epidemiology in a time of scientific innovation and budgetary constraints
Q36968401Review Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine
Q24289206The next generation of large-scale epidemiologic research: implications for training cancer epidemiologists
Q28072100Transdisciplinary approaches enhance the production of translational knowledge
Q24289006Transforming Epidemiology for 21st Century Medicine and Public Health
Q45997237Why precursors matter.

Search more.